Gilead Withdraws Request for Special Orphan Status on Experimental Coronavirus Treatment
Critics said the company was profiteering from the coronavirus pandemic by seeking tax and monopoly benefits under a program intended to encourage drug development for rare diseases. [Source]
Publication Date:Origin: nytimes.com
Category: Drugs (Pharmaceuticals)
Topics: diseases, development, encourage, intended, program, under, benefits, monopoly, seeking, pandemic, coronavirus, profiteering, company, Critics, Treatment, Coronavirus, Experimental, Status, Orphan, Special, Request, Withdraws, Gilead
Source: https://www.nytimes.com/2020/03/25/health/gilead-coronavirus-orphan-drug.html